P. Jenkinson

发表

Real-world effectiveness and safety of Vedolizumab for the treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort.

C. Lees, P. Brennan, C. Mowat, 2019, Journal of Crohn's & colitis.

The ACE (Albumin, CRP and Endoscopy) Index in Acute Colitis: A Simple Clinical Index on Admission that Predicts Outcome in Patients With Acute Ulcerative Colitis.

C. Lees, J. Satsangi, I. Arnott, 2020, Inflammatory bowel diseases.

IBD prevalence in Lothian, Scotland, derived by capture–recapture methodology

C. Lees, P. Henderson, I. Arnott, 2019, Gut.

Analysis of colectomy rates for ulcerative colitis in pre‐ and postbiological eras in Lothian, Scotland

C. Lees, I. Arnott, K. Kirkwood, 2020, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Temporal Trends in Surgical Resection Rates and Biologic Prescribing in Crohn's Disease: A Population-based Cohort Study.

C. Lees, I. Arnott, S. Siakavellas, 2020, Journal of Crohn's & colitis.

Implementation of CT-P13 via a Managed Switch Programme in Crohn’s Disease: 12-Month Real-World Outcomes

C. Lees, I. Arnott, G. Ho, 2018, Digestive Diseases and Sciences.

Patterns of emergency admission for IBD patients over the last 10 years in Lothian, Scotland: a retrospective prevalent cohort analysis

C. Lees, R. Russell, P. Henderson, 2022, Alimentary pharmacology & therapeutics.

Real‐world effectiveness and safety of ustekinumab for the treatment of Crohn's disease: the Scottish ustekinumab cohort

C. Lees, C. Mowat, D. Gaya, 2020, Journal of gastroenterology and hepatology.

Higher anti-tumor necrosis factor levels are associated with perianal fistula healing and fistula closure in Crohn's disease.

C. Lees, I. Arnott, N. Plevris, 2019, European journal of gastroenterology & hepatology.

OWE-04 A capture-recapture study of all-age IBD point prevalence in scotland

C. Lees, P. Henderson, Sarah E. Minnis, 2019, Inflammatory Bowel Disease.

Faecal Calprotectin and Magnetic Resonance Enterography in Ileal Crohn’s Disease: Correlations Between Disease Activity and Long-Term Follow-Up

C. Lees, N. Kennedy, S. Glancy, 2018, Journal of Crohn's & colitis.

Normalization of Fecal Calprotectin Within 12 Months of Diagnosis is Associated with Reduced Risk of Disease Progression in Patients with Crohn's Disease.

C. Lees, I. Arnott, S. Siakavellas, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

PTU-002 Achieving biochemical remission in crohn’s disease with adalimumab therapy utilsing therapeutic drug monitoring

C. Lees, I. Arnott, C. Noble, 2018, IBD.

Higher Adalimumab Drug Levels During Maintenance Therapy for Crohn's Disease Are Associated With Biologic Remission.

C. Lees, I. Arnott, G. Ho, 2018, Inflammatory bowel diseases.

Association of trough vedolizumab levels with clinical, biological and endoscopic outcomes during maintenance therapy in inflammatory bowel disease

C. Lees, I. Arnott, R. Pattenden, 2019, Frontline Gastroenterology.

Effectiveness and Safety of Adalimumab Biosimilar SB5 in Inflammatory Bowel Disease: Outcomes in Originator to SB5 Switch, Double Biosimilar Switch and Bio-Naïve SB5 Observational Cohorts

C. Lees, I. Arnott, S. Siakavellas, 2021, Journal of Crohn's & colitis.

Modified use of Kocher's dissector in ligation of the superior thyroid pedicle

M. Syed, P. Jenkinson, S. Denholm, 2013, The Journal of Laryngology & Otology.

Rates, predictive factors and effectiveness of ustekinumab intensification to 4- or 6-weekly intervals in Crohn's disease.

C. Lees, I. Arnott, S. Siakavellas, 2022, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

OWE-27 Analysis of UC colectomy rates in pre- and post- biologic era South-East Scotland

C. Lees, M. Dunlop, I. Arnott, 2019, Colon and Anorectum.

Faecal calprotectin and MRI Enterography in ileal Crohn's disease: correlations between disease activity and long term follow up.

C. Lees, N. Kennedy, S. Glancy, 2018 .

P459 Vedolizumab for the treatment of chronic pouchitis: the Edinburgh experience

C. Lees, I. Arnott, A. Shand, 2019, Journal of Crohn's and Colitis.